Medical
Arvinas ARV-102: The First ‘Protein Destroyer’ Drug for Parkinson’s — What the New Phase 1 Data Actually Shows (2026)
Arvinas presented Phase 1 data for ARV-102, an oral PROTAC drug that destroys the LRRK2 protein, at the…
Arvinas presented Phase 1 data for ARV-102, an oral PROTAC drug that destroys the LRRK2 protein, at the…
Crypto hackers have stolen $2.81 billion in 2026, CertiK data shows, with October already at $116.1 million across…